NIH Halts Hydroxychloroquine Study; Says ‘Unlikely’ To Help COVID-19 Patients

Senate Minority Leader Chuck Schumer, D-N.Y., holds a bottle of hydroxychloroquine while raising concerns about its use.

The NIH said that while the anti-malarial drug did not cause harm to patients in the study, testing showed little evidence that it would benefit patients hospitalized with COVID-19.

(Image credit: Lev Radin/Pacific Press/Pacific Press/LightRocket via Ge)

Leave a Reply

Your email address will not be published. Required fields are marked *